Preventative Treatments

#baseSelector{margin-bottom:1.6em}#baseSelector h2{color:#003160;font-weight:600;font-size:1.6em}#baseSelector li{margin-bottom:.5em}#baseSelector p{margin-bottom:.5em}#baseSelector a{text-decoration:underline;color:#003160;font-weight:600;margin-bottom:1em}#baseSelector img.watermark{position:absolute;bottom:1em;right:1em;width:13.125em;opacity:.25}#red_atlc_condition_management_sub_title-block_5cc6dd5f39fd4{color:#003160;margin-bottom:1.6em}#red_atlc_condition_management_sub_title-block_5cc6dd5f39fd4 h2.sub-title{font-size:1.25em;font-weight:400;margin-bottom:1em}#red_atlc_condition_management_sub_title-block_5cc6dd5f39fd4 p{margin:0} Gene therapy is currently in clinical trials for both Adrenoleukodystrophy and Metachromatic Leukodystrophy with very promising results.

#baseSelector{margin-bottom:1.6em}#baseSelector h2{color:#003160;font-weight:600;font-size:1.6em}#baseSelector li{margin-bottom:.5em}#baseSelector p{margin-bottom:.5em}#baseSelector a{text-decoration:underline;color:#003160;font-weight:600;margin-bottom:1em}#baseSelector img.watermark{position:absolute;bottom:1em;right:1em;width:13.125em;opacity:.25}#red_atlc_condition_management_sub_title-block_5cc6dbc401f08{color:#003160;margin-bottom:1.6em}#red_atlc_condition_management_sub_title-block_5cc6dbc401f08 h2.sub-title{font-size:1.25em;font-weight:400;margin-bottom:1em}#red_atlc_condition_management_sub_title-block_5cc6dbc401f08 p{margin:0} Bone Marrow Transplants have successfully been used for many years to treat individuals with asymptomatic Adrenoleukodystrophy, with a Loes score of less than 8.

#baseSelector{margin-bottom:1.6em}#baseSelector h2{color:#003160;font-weight:600;font-size:1.6em}#baseSelector li{margin-bottom:.5em}#baseSelector p{margin-bottom:.5em}#baseSelector a{text-decoration:underline;color:#003160;font-weight:600;margin-bottom:1em}#baseSelector img.watermark{position:absolute;bottom:1em;right:1em;width:13.125em;opacity:.25}#red_atlc_condition_management_sub_title-block_316e7eec5e45c13e6f602c9f7e523d84{color:#003160;margin-bottom:1.6em}#red_atlc_condition_management_sub_title-block_316e7eec5e45c13e6f602c9f7e523d84 h2.sub-title{font-size:1.25em;font-weight:400;margin-bottom:1em}#red_atlc_condition_management_sub_title-block_316e7eec5e45c13e6f602c9f7e523d84 p{margin:0} Adrenoleukodystrophy; Giant Axonal Neuropathy; Glutaric acidemia type 1; Krabbe Disease; Metachromatic Leukodystrophy